The intricate interplay between calcium and bone metabolism is a subject of ongoing exploration in medical science. This review aims to elucidate this complex relationship, offering healthcare professionals a deeper understanding of the mechanisms involved and their implications for patient care.
Calcium is essential for bone health. It is a primary component of hydroxyapatite, the mineral matrix that gives bones their strength and rigidity. In addition to its structural role, calcium also functions as a signaling molecule, regulating the activity of osteoblasts and osteoclasts, the cells responsible for bone formation and resorption respectively.
Calcium homeostasis is tightly controlled by a series of hormonal feedback mechanisms. Parathyroid hormone (PTH), vitamin D, and calcitonin orchestrate the balance between calcium absorption, excretion, and bone deposition. Disruptions in this equilibrium can lead to pathological bone conditions, such as osteoporosis and hypercalcemia.
Calcium supplementation is often recommended for the prevention and treatment of osteoporosis. However, the benefits and risks of calcium supplementation are still under debate. While some studies suggest a positive effect on bone mineral density, others raise concerns about potential cardiovascular risks associated with high calcium intake.
Understanding the complex relationship between calcium and bone metabolism is crucial for healthcare professionals. It informs decisions regarding dietary advice, supplementation, and the management of bone-related disorders. Further research is needed to fully elucidate the implications of calcium homeostasis on bone health and to optimize therapeutic strategies for the prevention and treatment of bone diseases.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation